Induction of premature senescence by hsp90 inhibition in small cell lung cancer.

BACKGROUND: The molecular chaperone Hsp90 is a promising new target in cancer therapy and selective Hsp90 inhibitors are currently in clinical trials. Previously these inhibitors have been reported to induce either cell cycle arrest or cell death in cancer cells. Whether the cell cycle arrest is rev...

Full description

Bibliographic Details
Main Authors: Ian J Restall, Ian A J Lorimer
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2010-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC2884022?pdf=render